Company records / evqlv.com
EVQLV
EVQLV (evqlv.com): 3 changes recorded in its website history since May 2020.
Recorded changes
- HeadlineBetween and
EVQLVing the design and development of antibodies
The easiest path to AI for antibody scientists
- HeadlineBetween and
EVQLVing the speed that healing reaches those in need
EVQLVing the design and development of antibodies
- HeadlineBetween and
Accelerating Biologic Therapies with the power of artificial intelligence
Accelerating the speed that healing
First recorded website
Observed 29 May 2020
How it described itself
Artificial Intelligence
EVQLV develops artificial intelligence for the discovery and acceleration of biologic therapeutics.
How it describes itself
The easiest path to AI for antibody scientists
Inspect 5 captures in this group
- ·
The easiest path to AI for antibody scientists
archived page - ·
The easiest path to AI for antibody scientists
archived page - ·
The easiest path to AI for antibody scientists
archived page - ·
The easiest path to AI for antibody scientists
archived page - ·
The easiest path to AI for antibody scientists
archived page
- ·
EVQLVing the design and development of antibodies
Inspect 3 captures in this group
- ·
EVQLVing the design and development of antibodies
archived page - ·
EVQLVing the design and development of antibodies
archived page - ·
EVQLVing the design and development of antibodies
archived page
- ·
EVQLVing the speed that healing reaches those in need
Inspect 2 captures in this group
- ·
Accelerating the speed that healing
archived page - ·
EVQLVing the speed that healing reaches those in need
archived page
- ·
Accelerating Biologic Therapies with the power of artificial intelligence
Inspect 2 captures in this group
- ·
Artificial Intelligence
archived page - ·
Accelerating Biologic Therapies with the power of artificial intelligence
archived page
- ·
Summary of the record · AI-written
EVQLV revises homepage messaging on antibody AI
EVQLV’s homepage headlines have shifted from general biologic therapies language toward positioning around AI support for antibody scientists.
- Between August 2020 and August 2021, EVQLV changed its homepage headline from “Accelerating Biologic Therapies with the power of artificial intelligence” to “Accelerating the speed that healing”. [1]
- Between January 2022 and March 2023, EVQLV changed its homepage headline to “EVQLVing the design and development of antibodies”. [2]
- Between July 2024 and January 2025, EVQLV changed its homepage headline to “The easiest path to AI for antibody scientists”. [3]
- Reading: The changes in homepage headlines across these periods suggest a sharpening focus on AI tools for antibody-related work and on antibody scientists as a target audience. [1][2][3]
Cite this record
StartupHistory, “EVQLV” company record, https://startuphistory.org/c/evqlv.com